8 employees
Anagin is developing first-in-class therapies for treating neuropsychiatric diseases.
2014
$267K
from 2 investors over 2 rounds
Anagin Inc raised undisclosed on January 1, 2017
Investors: Elevate Ventures
Anagin Inc raised $267K on March 9, 2016
Investors: National Institute of Neurological Disorders and Stroke (NINDS)